Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000812295-03-000071
Filing Date
2003-02-14
Accepted
2003-02-14 15:31:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 osipharm123102.txt SC 13G/A 5047
  Complete submission text file 0000812295-03-000071.txt   7471
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 03567363
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 100 FILLMORE STREET 2ND FLOOR DENVER CO 80206-4923
Business Address 100 FILLMORE STREET 2ND FLOOR DENVER CO 80206-4923 3033333863
JANUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000812295 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
SIC: 0000